1h
Hosted on MSNSoftware Stock Hits All-Time High Amid Generative AI Transformer Push, Eyes New Buy PointClearwater Analytics hit an all-time high and has formed a base amid fourth-quarter earnings. The stock leads the ...
Hosted on MSN1mon
Clearwater Analytics to buy Enfusion for $11.25 a shareClearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately equal mix of cash and stock. Clearwater (NYSE:CWAN) is expected to pay ...
BOISE, Idaho & CHICAGO--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their ...
Clearwater Analytics' $1.5 billion acquisition of Enfusion is a strategic move to expand its portfolio management offerings and enhance its SaaS revenue growth. Enfusion's strong business model ...
Piper Sandler analyst Arvind Ramnani upgraded Clearwater Analytics to Overweight, increasing the price target to $36 from $28 ...
Clearwater Analytics Holdings' 4Q24 performance shows strong revenue growth momentum. See why I continue to rate CWAN stock ...
In a report released yesterday, Michael Infante from Morgan Stanley maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research Report), with a price target of $34.00. Michael ...
CEO at Clearwater Analytics. “Our announced acquisition of Enfusion is a game changer. This pivotal milestone will broaden our horizons for growth and allow us to extend additional products to ...
Shares of Clearwater Analytics Holdings climbed after the company logged higher-than-expected profit and revenue in the fourth quarter, and issued outlooks that beat Wall Street's estimates. The stock ...
Piper Sandler analyst Arvind Ramnani upgraded the shares of Clearwater Analytics Holdings Inc (NYSE ... 03 rise from the same period last year. The Enfusion acquisition is expected to finalize ...
Piper Sandler analyst Arvind Ramnani upgraded the shares of Clearwater Analytics Holdings Inc (NYSE ... the previous quarter and a $0.03 rise from the same period last year. The Enfusion acquisition ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results